Humana Inc.’s HUM CenterWell Senior Primary Care is participating in a new federal health program. This will allow the unit to expand its medical facilities for the original Medicare beneficiary care team.
In particular, CenterWell is a leading provider of senior-friendly healthcare, operating 67 non-paying primary care centers in eight states. It is part of Humana’s Care Delivery Organization, in which around 100 Conviva Care Centers are involved. Together with Conviva, CenterWell serves more than 2,000,000 elderly patients in the United States.
Both segments are making good progress, as evidenced by CenterWell’s upcoming expansion into the ninth state this year. It is part of the new direct contract model with the sole aim of providing Medicare beneficiaries with improved healthcare and a better patient experience.
Medicare members will enjoy improved health care at a reasonable cost. This holistic approach to treatments is expected to lead to better health outcomes. While Humana has long addressed the needs of Medicare Advantage patient care under this healthcare model, it is now expanding the same facility to include Original Medicare members.
The move comes at the right time, as today every individual strives for high-quality and value-oriented care. CenterWell’s reimbursement under this model depends on the standard of care it offers. For example, the financial burden of medical costs is shared between the Centers for Medicare & Medicaid Services (CMS) and CenterWell. The direct contract model launched by the CMS Innovation Center encourages health organizations to voluntarily move from paid to value-based care.
This is definitely not the first time Humana has taken steps to enrich the experience of its members. Earlier this year, the health insurer launched a pilot project called Humana Care Support, which provides a variety of tailored, integrated, and coordinated care management services to a specific group of Medicare Advantage members.
The leading health insurer is steadily benefiting from its Medicare business. In the first quarter of 2021, the number of members increased by 12% compared to the previous year. For the full year, this currently ranked 3rd (Hold) player from Zacks expects an individual Medicare Advantage membership growth of approximately 425,000-475,000 members, an increase of 11-12% over the number reported last year. This in turn should contribute to solid sales growth.
The story goes on
Value for money
Humana shares are up 9.6% in a year, below the industry’s 29.4% gain. You can see The full list of today’s Zacks # 1 Rank stocks can be found here.
Zacks Investment Research
Image source: Zacks Investment Research
Shares to Consider
There are some better rated companies in the same field Magellan Health, Inc. MGLN, Choose Medical Holdings Corporation REM and The common corp. JYNT, everyone currently holds a Zacks rank # 2 (Buy).
Magellan Health, Select Medical, and Joint Corp. managed to get a surprise of 69.6%, 245.9% and 199.2% on average in the fourth quarter, respectively.
Zacks names “Best Single Pick to Double”
From thousands of stocks, 5 Zacks experts have each selected their favorite, which will skyrocket + 100% or more in the coming months. Of these 5, Research Director SherazMian picks one that has the most explosive advantage of them all.
You know this company from its past glory days, but few would expect it to face a monster turnaround. Fresh from a successful repositioning and plentiful with A-list celebrity endorsements, it could double with other Zacks’ recent stocks like Boston Beer Company, which shot + 143.0% in just over 9 months , and Nvidia, which boomed +175.9%, will compete or surpass% in a year.
Free: Check out our top stocks and 4 runners-up >>
Would you like the latest recommendations from Zacks Investment Research? Today you can download the 7 best stocks for the next 30 days. Click here to get this free report
Humana Inc. (HUM): Free Stock Analysis Report
Magellan Health, Inc. (MGLN): Free Stock Research Report
Select Medical Holdings Corporation (SEM): Free Stock Analysis Report
The Joint Corp. (JYNT): Free Stock Analysis Report
To read this article on Zacks.com, click here.
Zacks Investment Research
Read More Now